Medicus Pharma has received authorisation from the UAE Department of [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

Kairos Pharma and Bayer will evaluate ENV-105 in combination with [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

The European Medicines Agency (EMA) has accepted Almirall’s application to [...]